Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Ondine Biomedical Inc. is a Canada-based biotechnology company. The Company is engaged in the development and commercialization of anti-infective therapies covering a various bacterial, fungal and viral infections primarily using antimicrobial photodynamic therapy (aPDT) as a platform technology for its products, which are used as an alternative to the use of antibiotics. The Company¿s aPDT products uses laser-based activation of compounds to treat a range of medical infections. Its Photodisinfection platform, is a light-based antimicrobial technology that provides rapid destruction of a range of pathogens without causing antibiotic resistance. The Company offers Steriwave product, which is a photodisinfection-based medical device to eliminate harmful nasal pathogens that can lead to healthcare-associated infections (HAIs).
| Last: | $0.17 |
|---|---|
| Change Percent: | -98.97% |
| Open: | $0.17 |
| Close: | $0.17 |
| High: | $0.17 |
| Low: | $0.17 |
| Volume: | 40,000 |
| Last Trade Date Time: | 11/05/2025 09:30:48 am |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Ondine Biomedical (OTCMKTS: OBIMF).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.